arrow
F

Florence Guivel-Benhassine

universite paris cite
H指数:37
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1

温度依赖性复制和对人冠状病毒HKU1先天免疫的敏感性

2026-07-270
OAAI
Complement augments antibody neutralization of SARS-CoV-2 variants

补体增强抗体对SARS-CoV-2变种的中和作用

2026-07-220
PRE
Potent neutralization by antibodies targeting the MPXV A28 protein

针对MPXV A28蛋白的抗体的强效中和作用

2025-12-100
OA
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153

抗原非依赖性鉴定靶向OPG153的痘病毒广谱中和抗体

2025-12-100
PRE
Stealth replication of SARS-CoV-2 Omicron in the nasal epithelium at physiological temperature

SARS-CoV-2 Omicron在生理温度下于鼻上皮细胞的隐秘复制

2025-12-011
PRE
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection

痘病毒融合调控及抗A16/G9抗体介导的中和与保护的结构基础

Cell
IF42.5
2025-08-260
OAAI
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024-03-1345
OAAI
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants

Β-变体重组加强疫苗引起包括Omicron变体在内的SARS-CoV-2的广泛交叉反应中和

HELIYON
IF3.6
2024-03-011
OAAI
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
2024-01-233
OA
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis
2023-10-203
OAAI
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
MED
IF11.8
2023-10-018
OAAI
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Omicron亚变体BA.2.75.2,BA.4.6和BQ.1.1对中和抗体的抗性

2023-02-14105
OAAI
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

接受单克隆抗体的患者血清中和SARS-CoV-2 Omicron BA.2,BA.4和BA.5的纵向分析

2022-12-0145
OAAI
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
2022-09-0118
OAAI